Bausch Health Companies Inc. Common Stock (BHC)
R&D Expense Growth
6.13%
Quarterly · Period ending:
BHC R&D Expense Growth
Latest reported6.13%period ending
Latest reported6.13%period ending
BHC Quarterly R&D Growth (QoQ) (0.00% → 6.13%)
Latest values, visible window
High-resolution chart · PNG
BHC r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 21.969% | |
| 169.16% | |
| -81.3411% | |
| 62.9106% | |
| 18.494% | |
| -13.4853% | |
| 76.6234% | |
| 18.4615% | |
| 22.6415% | |
| 0% | |
| 32.5% | |
| -2.439% | |
| 2.5% | |
| 0% | |
| -100% | |
| 113.0435% | |
| -25.8065% | |
| 93.75% | |
| -11.1111% | |
| -10% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |